contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


scandidos-receives-orders-worth-euro478-000-from-china

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Scandidos operates in the medical technology sector. The company offers products and systems for quality assurance of advanced radiation therapy for cancer. The systems analyze the radiation dose before and during ongoing radiation treatment. The company was founded in 2002 and the first product was launched in 2006. Since its inception, Scandidos has delivered products to radiation therapy clinics on a global level. The head office is located in Uppsala.

Scandidos

ScandiDos has received a combined order totaling 478 000 EUR for multiple Delta4 Phantom+ measurement systems. This significant deal results from collaboration with the reputable distributor...

<div class="mfn-body"><p>ScandiDos has received a combined order totaling 478 000 EUR for multiple Delta4 Phantom+ measurement systems. This significant deal results from collaboration with the reputable distributor, Beijing HGPT Technology &amp; Trade Co. Ltd, and concerns several prominent hospitals in China. Anticipated deliveries of the measurement systems are scheduled during the current quarter.</p><p>ScandiDos has seen considerable demand for its products in China in the past year. The growing business is attributed to the increasing need for advanced radiotherapy treatment technologies to handle the booming cancer patient population. Delta4 Phantom+ has become the preferred choice for more than 100 hospitals in China.</p><p>“In 2023, Asia has proven to be the market where we've achieved our greatest success, and the Chinese market is no exception. The notable demand for ScandiDos' patient QA solutions in China is a testament to our successful establishment as a reliable partner. Our innovative products effectively meet the demands for workflow and efficiency set by Chinese hospitals and clinics," says Gustaf Piehl, CEO of ScandiDos."</p></div><div class="mfn-footer mfn-contacts mfn-a0f36c52b51a"><p><strong class="mfn-heading-1">CONTACT</strong></p><hr><p>Gustaf Piehl, CEO, ScandiDos: <a rel="noopener" href="mailto:investor@scandidos.com">investor@scandidos.com</a>, +46 18-472 30 20<br>ScandiDos AB (publ), 556613-0927<br>Uppsala Science Park, 751 83 Uppsala</p></div><div class="mfn-footer mfn-about mfn-ee6b908a1445"><p><strong class="mfn-heading-1">ABOUT SCANDIDOS</strong></p><hr><p>ScandiDos is an innovative forward-thinking company with groundbreaking software and hardware solutions for patient quality assurance in modern radiation therapy. Our Delta4 Family of products delivers a comprehensive QA solution, making the treatment process safe and efficient. We reinforce the confidence in radiotherapy clinics by providing professionals at the clinics with power and performance through independent QA.</p><p>The head office is in Uppsala Science Park, where product development is carried out. Sales are carried out by sales offices in the USA, Malaysia, and France, directly in the Nordic countries and through distributors&nbsp;in over 50 countries.</p><p>ScandiDos is listed on NASDAQ First North Stockholm with the ticker code SDOS. Certified adviser is Erik Penser Bank. Additional investor information can be found at <a rel="noopener" href="https://scandidos.com/?utm_source=mfn&amp;amp;utm_medium=pr&amp;amp;utm_campaign=about">Scandidos.com</a>. Product information can be found on <a rel="noopener" href="https://delta4family.com?utm_source=mfn&amp;utm_medium=pr&amp;utm_campaign=about">Delta4family.com</a></p></div><div class="mfn-footer mfn-regulatory mfn-regulatory-mar"><p><em>This information is information that ScandiDos is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-12-20 09:03 CET.</em></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/eab922cf-9999-49ad-8987-2d8bcb737b00/scandidos-receives-orders-worth-eu478-000-from-china.pdf" class="mfn-generated mfn-primary">ScandiDos receives orders worth €478 000 from China</a></p></div>